Articles
Phylogica hit with two market setbacks
Phylogica's (ASX:PYC) research partner Janssen Pharmaceuticals has elected not to license the outcome of their collaboration and a Phylogica licensee has filed for bankruptcy. [ + ]
A powerful body scanner for an advanced imaging facility
The University of Queensland's Centre for Advanced Imaging has acquired an $11 million 7 T MRI scanner, said to be the most powerful body scanner in the Southern Hemisphere. [ + ]
Virax names new managing director
Virax Holdings (ASX:VHL) has announced that former Arana Therapeutics executive Dr Rob Crombie will join the company as managing director in mid-June. [ + ]
Australia's scientists react to the Budget
The 2014-15 Budget will affect several areas of science, provoking comments from experts involved in the industry. [ + ]
CSL opens recombinant therapy plant in Vic
CSL (ASX:CSL) has opened a biotechnology manufacturing plant in Melbourne as part of a $257m expansion of its Broadmeadows facilities. [ + ]
GI Dynamics expands reach of EndoBarrier in AU
GI Dynamics (ASX:GID) has revealed that two more Australian sites are offering its obesity and diabetes device therapy EndoBarrier and has published research into the treatment's mechanism of action. [ + ]
Building bone marrow-on-a-chip
Researchers from the Wyss Institute have created a new organ-on-a-chip - a microfluidic device that mimics the physiology of a living organism. The device reproduces the structure, functions and cellular make-up of bone marrow. [ + ]
Prima gets FDA fast-track status for CVac
Shares in Prima BioMed grew 30% after the company revealed it has won fast-track designation in the US for CVac in platinum-sensitive epithelial ovarian cancer in second remission. [ + ]
Scientists create a superheavy element
An international research team has created and observed several atoms of the superheavy element with atomic number 117. The measured properties of the atoms strengthen the case for official recognition of 117 as a new element. [ + ]
Novogen forms child cancer R&D partnership
Novogen (ASX:NRT) has entered separate research collaborations aimed at adapting its super-benzopyran drugs to treat solid childhood cancers and neurodegenerative diseases. [ + ]
Fibrotech bought by Shire for at least $81m
Melbourne-based biopharma Fibrotech has agreed to be bought out by Shire for an initial US$75 million ($80.9 million). The deal will also involve development and regulatory milestone payments. [ + ]
CardioCel calcification-free after six years: Admedus
The six-year follow-up for the first patient enrolled in a phase II trial of Admedus's CardioCel tissue patch has detected no calcification issues or complications. [ + ]
Bake your own microscope lens
Australian scientists have invented a simple way of making a high-powered lens that costs less than a cent and can transform a smartphone into a high-resolution microscope. [ + ]
The microRNA perspective
The persistently high blood glucose levels associated with diabetes can, over time, cause damage to blood vessels that result in so-called diabetes-related complications. Preventing or reducing diabetes-related complications in the kidney is the focus of some of the work currently underway at the Baker IDI. [ + ]
Cochlea implant delivers gene therapy
Electrical pulses delivered from a cochlear implant have been used to deliver gene therapy and succesfully regrow auditory nerves. [ + ]
